Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma

Abstract Background Choriocarcinoma is a rare and aggressive gynecological malignancy. The standard treatment is systemic chemotherapy as choriocarcinoma exhibits high chemosensitivity. However, refractory choriocarcinoma exhibits chemoresistance; thus, the prognosis remains very poor. This study ai...

Full description

Bibliographic Details

Published in:	Cancer Medicine
Main Authors:	Eri Watanabe, Akira Yokoi, Kosuke Yoshida, Mai Sugiyama, Masami Kitagawa, Kimihiro Nishino, Eiko Yamamoto, Kaoru Niimi, Yusuke Yamamoto, Hiroaki Kajiyama
Format:	Article
Language:	English
Published:	Wiley 2023-02-01
Subjects:	choriocarcinoma drug repositioning ferroptosis histone deacetylase inhibitors vorinostat
Online Access:	https://doi.org/10.1002/cam4.5243